🎯 check LY2835219 (Abemaciclib) Mesylate product page
LY2835219 (Abemaciclib) Mesylate is a potent, selective, and reversible ATP-competitive CDK4/6 inhibitor. It affects Rb/E2F signaling by blocking retinoblastoma protein phosphorylation, effectively inhibiting G1 to S phase cell cycle progression and tumor cell proliferation.